Vol. 3, No. 6 — June 2026Independent since 2024

TheCompound Journal

Reporting on incretins, compounding & the peptide supply chain

A monthly journal of record.
30 issues · 32 contributors
Not medical advice. We sell nothing.

Documents

How a release document is put together in a regulated plant

Nothing on this page is difficult. It is simply unfamiliar, and unfamiliarity is what makes a weak certificate look like a strong one.

A certificate of analysis is not a test result. It is a statement, made by whoever signs it, that a defined quantity of material identified by a batch number was subjected to defined tests by defined methods and produced results within defined limits on a defined date. Every element of that sentence is load-bearing, and a document missing any of them is not a weak certificate but a different kind of object: an assertion of quality with no way back to the evidence. The Journal has read several hundred of these and the distribution is not encouraging, though the reason is more mundane than the trade’s more excitable commentary suggests.

The header block: identifying the object

The top of a certificate answers the question, what is this document about. A complete header names the product, gives a catalogue or item number, gives the batch or lot number, states the quantity or fill weight, names the manufacturer and the site, and identifies the customer or order where applicable. Some add a chemical name, a sequence in single-letter code, a molecular formula and a molecular weight, all of which are useful because they let a reader check the theoretical values used elsewhere on the page.

The sequence in particular is worth insisting on. A certificate that prints the one-letter sequence has given a reader the means to calculate the expected mass independently, and therefore to check the identity line. Two of the twenty companies in the Journal’s dossier programme do this as standard. It costs nothing and it converts one line of the document from an assertion into a verifiable claim.

What a header should never do is identify the product only by a trade name. A vial described as a proprietary blend with no chemical identity, no formula and no sequence cannot be checked against anything, and a certificate for such a product is a document about a name. This is a documentary observation rather than an accusation, and the remedy is trivial: print the sequence.

The test table: four columns, and most certificates carry two

The body of a certificate is a table, and a complete one has four columns: the test performed, the method used, the specification applied, and the result obtained. Four columns, one row per test. That structure is not a convention peculiar to pharmaceuticals; it is what a record of controlled testing looks like in any field, because each column answers a question the other three cannot.

The method column is where the detail belongs — not the word HPLC but a method identifier, a gradient, a wavelength, a column chemistry. The specification column states what the batch had to achieve. The result column states what it did. A certificate carrying only test and result has dropped the two columns that make the result interpretable, and this is by far the commonest structural deficiency the Journal encounters.

The compendial framework for validating an analytical procedure exists precisely to establish that a stated method can discriminate what it claims to discriminate, which is why a method reference is not bureaucratic ornament but the hook on which everything else hangs.12 A named method can be looked up, compared, criticised and repeated. An unnamed one cannot be, and a result generated by one is a number whose provenance stops at the page.

The analytical work behind these products is often better than the paperwork that reports it.

On why a bad document is not a bad product

The lines nobody reads: appearance and solubility

Near the top of most test tables sit two entries that buyers skip and chemists do not: appearance and solubility. Appearance is reported as something like “white to off-white lyophilised powder”, and it is a real test with real discriminating power. A peptide cake that is yellow, or grey, or that has collapsed into a glassy plug rather than a light lyophilised mass, is telling you something about the drying cycle, about oxidation, or about a temperature excursion in transit.

Solubility is similarly underrated. A specification reading “clear, colourless solution on reconstitution in water at 1 mg/mL” establishes that the material dissolves at the concentration a user will need, without haze, and haze on reconstitution is a genuine finding: it can indicate aggregation, incomplete removal of a protecting group, or particulate contamination. It is also the only test on most certificates that a buyer can repeat at home.

The reason to press on these lines is that they are cheap, they are already on the form, and they degrade in a way the purity figure does not capture. A certificate reporting a white powder for material that arrives faintly yellow has not been falsified. It has been overtaken by events, which is exactly what a certificate with an eleven-month-old date of analysis should be expected to be.

Which elements appear on twenty suppliers’ certificates
ElementCertificates carrying it (of 20)
Product name and batch number20
Purity result20
Date of analysis18
Identity test of any kind14
Appearance13
A name in the signature block11
Date of manufacture10
Specification column present for all tests9
Named method with gradient or wavelength7
Sequence printed in single-letter code6
Retest or expiry date with convention stated5
Water content4
Peptide content3
Counter-ion identity and content2
Two signatures in the regulated pattern2
Statement linking bulk lot to fill lot3
Counts are of the most recent certificate supplied to the Journal by each of the twenty companies in the dossier programme, at the last quarterly cycle. Several companies supply additional information on request that does not appear on the standard document; those cases are credited here only where the element appears on the certificate itself.

Water, counter-ion and the mass in the vial

A lyophilised peptide is not pure peptide even when it is chromatographically pure. It is a salt, usually of trifluoroacetic or acetic acid, containing residual water that a hygroscopic powder acquires readily, and sometimes residual solvent from purification. Three lines on a certificate address this and they are usually absent: water content, counter-ion identity and content, and residual solvent.

Water is determined by Karl Fischer titration or by loss on drying, and the pharmacopoeial methods for it are old, settled and inexpensive.3 A peptide containing eight per cent water by mass contains eight per cent less peptide than its label implies, and the figure is not stable: it depends on how the vial was stoppered and how long it has been open. Counter-ion content is a larger contribution still for basic peptides purified in trifluoroacetic acid, where the counter-ion fraction can reach ten to twenty per cent of total mass.4

Put these together and the practical statement is the one this department repeats: the nominal mass on a research vial is an upper bound on the peptide it contains, not a value. A certificate that reports purity and is silent on water and counter-ion has told you the material is clean and nothing at all about how much of it there is.

The footer: dates, signatures and the release statement

The bottom of a certificate carries the dates, the signatures and any boilerplate. A complete footer gives the date of manufacture, the date of analysis, and either a retest date or an expiry date with the convention named. It gives the name and role of the person who performed or compiled the testing, and separately of the person who reviewed and approved it. It states the storage conditions under which the stated properties hold. And it states, in a research-chemical context, the research-use-only restriction.

The two-signature convention is worth explaining because its absence is so universal here that its purpose is forgotten. Separating performance from approval is a control against a single person’s error or judgement determining a release. It is cheap, it requires no equipment, and it is the ordinary practice in every regulated laboratory. Its function is not ceremonial: it means that when a document turns out to be wrong, there is a record of who reviewed it and on what basis.

What the footer should not carry is a signature rendered as a reused image with no accompanying name. That is not evidence of anything improper on its own — scanned signature blocks are common in legitimate commerce — but it removes the one piece of information the block exists to supply, which is the identity of a person who can be asked.

The ten-minute check

Minute one: find the batch number on the certificate and find it on the vial. Not the carton. If they do not match, or the vial has no number, stop and ask the supplier what the relationship is. Minutes two and three: find the date of manufacture and the date of analysis, and compute the interval. Then compute the interval between the date of analysis and today.

Minutes four and five: read the test table and count the columns. If the specification column is missing, the results cannot be assessed. If the method column is missing or says only HPLC, the purity figure cannot be compared with anybody else’s. Minute six: check the identity line for a theoretical mass, and check whether the convention — monoisotopic or average — is stated. Minute seven: read the signature block for a name and a role.

Minutes eight to ten: list what is not there. Content, water, counter-ion, residual solvent, endotoxin, sterility. Then decide whether any of those matter for what you are doing, which is a question only the reader can answer. The exercise does not establish that a certificate is right or wrong. It establishes whether the document can be checked at all, and in the Journal’s experience roughly a third of certificates in general circulation fail before minute five. Readers who work through this and find something they cannot interpret are welcome to write to standards@compoundjournal.com.

The next piece in this department turns from the document to the institutions that generate it: the four independent testing services this market relies on, what each measures, and the awkward fact that in most cases the party paying for the test is the party being tested. Two of the four advertise in this publication, which is disclosed on our funding page and is stated again wherever the coverage touches them.

References

  1. United States Pharmacopeia. General chapter ⟨1225⟩, Validation of Compendial Procedures. USP–NF.
  2. International Council for Harmonisation. Q2(R2): Validation of Analytical Procedures. 2023.
  3. European Directorate for the Quality of Medicines. European Pharmacopoeia, general chapter 2.5.12, “Water: semi-micro determination.” Strasbourg.
  4. “Residual trifluoroacetate in synthetic peptide preparations: quantitation, salt exchange and the effect on nominal mass.” Journal of Peptide Science. 2016;22(11):702–710.

Related coverage